Hence, they are used for both acute and chronic inflammatory airway diseases.
Introduction
Chronic cough is one of the most common and distressing symptoms of respiratory diseases. One of the most representative airway disorders responsible for chronic cough is eosinophilic bronchitis [1] , including bronchial asthma, non-asthmatic eosinophilic bronchitis (NAEB) [2] , atopic cough (AC) [3] , and cough variant asthma (CVA) [4] . Coughs are caused by cough reflex hypersensitivity in NAEB and AC. Moreover, the cough reflex hypersensitivity in these patients, which is suggested to be associated with sensory neuropeptides and chemical mediators such as arachidonic acid metabolites [5] [6] [7] , histamine [8] and platelet activating factor (PAF), can become normalized after successful treatment [9] , such as with corticosteroids and antihistamines. However, some of these patients experience persisting cough despite high levels of these medications, and therefore, they are severely impaired in their quality of life.
Unfortunately, no effective therapy for such patients has yet been clearly established. Although affecting only a small proportion of all NAEB and AC sufferers, this problem is therefore crucial for clinicians.
Macrolide antibiotics (herein referred to as 'macrolides') are a well-characterized family of spectrum antimicrobials that are used to treat acute bacterial infections. Moreover, it has been shown that 14-and 15-membered, but not 16-membered, macrolides [10] possess immunomodulatory and anti-inflammatory activities to inhibit migration of neutrophils, production of reactive oxygen radicals and mucus hypersecretion. Such properties other than the antibiotic actions have been well studied and applied to the therapy for chronic neutrophilic inflammatory airway diseases, including diffuse panbronchiolitis (DPB) [11] and sinobronchial syndrome (SBS) [12] . In addition, the effects of macrolides on bronchial asthma have been investigated in recent clinical studies [13] [14] [15] [16] . These studies demonstrated that, in bronchial asthma, although the effects of macrolides on bronchcoconstriction remain controversial, the symptom score, including cough, was observed to improve [13, 15] by treatment with these agents. However, there have so far not been any reports concerning the effects of macrolides on the cough reflex hypersensitivity associated with the eosinophilic inflammatory airway diseases, such as NAEB and AC.
In this study, we investigated the effects of erythromycin (EM), azythromycin (AZM) and josamycin (JM), the representative agents for 14-, 15-, and 16-membered macrolides, respectively, on cough reflex sensitivity to inhaled capsaicin in an animal model of airway allergic inflammation with cough reflex hypersensitivity. We also examined the effects on the levels of chemical mediators and substance P (SP) in the bronchoalveolar lavage fluid (BALF) and neutral endopeptidase (NEP) activity in the tracheal tissue.
Methods

Animals
Male, albino, Hartley-strain guinea pigs weighing 200 to 220 g were obtained from the Sankyou Laboratory Service (Toyama, Japan). They were then quarantined in the Animal Research Center of Kanazawa University. All animal procedures carried out during this study complied with the standards set out in the Guidelines for the Care and Use of Laboratory Animals at the Takara-machi Campus of Kanazawa University. The total n value in this study was 144; namely, 40 
Study design
Three experimental groups (including Experiments A, B and C) were set at different times, respectively. Guinea pigs in each experimental group were in turn assigned to negative control (NC) groups, positive control (PC) groups and macrolides (EM for Experiment A, AZM for Experiment B or JM for Experiment C) groups (n = 8 for each group). The animals in the PC and macrolides groups were then actively sensitized and exposed to aerosolized antigens. In addition, the animals in the NC groups were exposed to aerosolized saline.
Every 12 h after the antigen challenge (total; four times), 2.5 ml/kg of EM solution at concentrations of 0.2, 2 or 20 mg/ml (final dose: 0.5, 5 or 50 mg/kg, respectively), AZM solution at a concentration of 20 mg/ml (final dose: 50 mg/kg) or JM solution at a concentration of 20 mg/ml (final dose: 50 mg/kg) were intraperitoneally administered to the animals in the macrolides groups. The animals in PC and NC groups were given the intraperitoneal vehicle (2.5 ml/kg of distilled water). At 48 h after the antigen or saline challenge, the cough reflex sensitivity to inhaled capsaicin was measured.
After the measurement of the cough reflex sensitivity, bronchoalveolar lavage (BAL) was performed, and then the tracheal segments (80 to 120 mg each) were resected and isolated from the animals. However, to investigate the effects of EM on the substance P (SP) levels in the BAL fluid (BALF), another experimental group (Experiment D) set-up was needed to avoid the influence of capsaicin inhalation. The NC, PC and macrolides group in Experiment D were performed under the same conditions as those in Experiment A, but they were not subjected to capsaicin provocation before the performance of BAL (n =8 for each group).
In addition, to investigate the effects of EM on the normal cough reflex sensitivity, Experiment E was also newly developed. The guinea pigs in Experiment E were not sensitized and they received either 2.5 ml/kg of EM solution at a concentration of 20 mg/ml (final dose: 50 mg/kg) or distilled water in the same manner as that used for experiment A (n = 8, respectively). At 48 h after the first administration of either EM or vehicle, the cough reflex sensitivity to inhaled capsaicin was then measured.
Active sensitization
The guinea pigs were actively sensitized to ovalbumin (OA) using a modification of the method described by Muraki et al. [17] . Briefly, each animal was pretreated with the intraperitoneal administration of 30 mg/kg of cyclophosphamide. Two days later, the animals were immunized with 2.0 mg of OA and 100 mg of aluminum hydroxide [Al(OH) 3 ]. A booster injection of 0.01 mg of OA and 100 mg of Al(OH) 3 was then carried out three weeks after the primary immunization. The naïve guinea pigs that were kept in the same surroundings as the active sensitization animals that were used for NC.
Antigen challenge.
Three weeks after the booster injection, the actively sensitized guinea pigs were intraperitoneally administered 20 mg/kg of diphenhydramine to avoid the onset of acute anaphylactic respiratory distress. Thirty minutes later, the conscious guinea pigs were challenged for 90 seconds with 10 mg/ml OA aerosol by a method described previously [6, 18, 19] . The animals in the NC group were not injected with diphenhydramine, but they did inhale aerosolized saline by the same method as that described for the sensitized guinea pigs. In addition, the cough response to inhaled capsaicin was measured 48 h after the antigen challenge.
Measurement of cough reflex sensitivity
Cough reflex sensitivity was measured by a method as described previously [6] .
Briefly, each conscious guinea pig was placed in an airtight custom-built transparent plastic box consisting of a head chamber (volume 1600 ml) isolated from the body chamber. The pressure in the body chamber was recorded.
Coughs were detected as a transient specific change in the pressure (a rapid inspiration followed by rapid expiration). To disregard the motion-and In addition, we examined the effect of EM on the cough reflex sensitivity in the naïve guinea pigs.
Bronchoalveolar lavage (BAL)
BAL was performed immediately after analyzing the cough reflex sensitivity to capsaicin by a method as described previously [18, 19] . Briefly, the guinea pigs were anaesthetized by the intraperitoneal injection of 75 mg/kg of sodium pentobarbital and they were placed in a supine position. Through the tracheal cannula the lungs were lavaged with 10 ml of saline solution (0.15 mM NaCl) 2 times (total: 20 ml).
Bronchoalveolar lavage fluid (BALF) analysis
The cells in the BALF were immediately stained with Turk solution and counted in duplicate with a hemocytometer (in a Burker chamber). Different cell counts (analyzing 300 cells) were made on a smear prepared by cytocentrifugation and stained with Wright-Giemsa. Subsequently, the BALF was centrifuged (1500 rpm for 10 min) and the supernatants were stored at -80 °C. For measurement of the SP levels in the BALF, we performed BAL and treated the BALF in another experimental set-up in which the guinea pigs were not subjected to capsaicin provocation at 48 h after the antigen challenge. 
Concentration of SP
Neutral endopeptidase (NEP) activity of tracheal tissue
The removed trachea was soaked in saline and homogenized by an ultrasonic homogenizer (SONIFIER 250, Branson Ultrasonics, Danbury, CT). The sample was centrifuged at 5000 rpm for 2 minutes. The supernatant was used as a tracheal sample.
The NEP activity in the tracheal sample was determined by a two-step reaction method as described previously [20] , using the substratesuccinyl-alanyl-alanyl-phenylalanyl-para-nitroanilide (Suc-Ala-Ala-Phe-p NA). Briefly, a total of 100 μl of the tracheal samples were incubated with Suc-Ala-Ala-Phe-p NA (final concentration: 4 mmol/l in Tris-HCl
[Sigma], pH 7.4) as the substrate in the presence or absence of phosphoramidon (final concentration: 2 μmol/l). The reaction (total volume: 250 μl) was measured in duplicate in a 96-well microtiter plate at room temperature.
The increase in specific absorbance at 405 nm (as a result of the accumulation of free p-nitroaniline) was determined at several time points (0-24 h) using a plate reader (EAR 340AT, SLT-Labinstruments, Grödiq, Austria). Several concentrations of aminopeptidase solution were used to construct the standard curve. The NEP activity was determined as the activity that could be inhibited by phosphoramidon and it was expressed as units/mg in reference to the standard curve. One unit represents the enzyme activity that is able to separate 1 μmol/min p NA from Suc-Ala-Ala-Phe-p NA at pH 7.4 at 25 °C.
Reagent
The following chemicals were used: ovalbumin (Sigma, St. Louis, MO), erythromycin (Abbott Japan Co., Ltd., Tokyo, Japan), azythromycin (LKT 
Statistical analysis
All the data are shown as the mean ± S.E.M. The differences among all groups for each experiment were analyzed using the Kruskal Wallis test. If the Kruskal
Wallis test was positive (P < 0.05), then the differences between any pair of groups in each experiment were analyzed using the Mann-Whitney U test (StatView 5.0 software program, SAS Institute Inc., Cary, NC), with the level of significance set at P < 0.05.
Results
Effects of macrolides on cough reflex sensitivity
The number of coughs, induced by 1.0 × 10 4 M of capsaicin, was significantly (P < 0.01) increased in the sensitized group that was administered distilled water (PC group) in comparison to the NC group (see Figure 1A, 1C and 1D ). EM both significantly and dose-dependently inhibited the antigen-induced increase in the number of coughs (P < 0.01) (see Figure 1A) . Although AZM also inhibited the antigen-induced increase in the number of coughs (P < 0.05) (see Figure 1C ), JM showed no such inhibition (see Figure 1D ).
The number of coughs induced by 1.0 × 10 6 M of capsaicin did not significantly differ between the NC, PC and macrolides groups (EM, AZM, JM, respectively) (see Figure 1A , 1C and 1D).
EM did not affect the number of capsaicin-induced coughs in the naïve guinea-pigs (see Figure 1B ).
Effects of macrolides on BALF cells
The total number of cells and the percentage of neutrophils and eosinophils in the BALF increased significantly in the PC group in comparison to the NC group (P < 0.01 and P < 0.01, respectively). EM inhibited the increase in the total number of cells dose-dependently (P < 0.01), whereas the percentage of neutrophils or eosinophils was unchanged (see Table 1A ). Likewise, AZM also inhibited the increase in the total number of cells (P < 0.05), and did not influence the proportion of leukocytes in the BALF (see Table 1B ). JM did not affect either the total number of cells or the proportion of leukocytes in the BALF (see Table 1C ). The concentration of SP in the BALF increased greatly in the PC group in comparison to the NC group (P < 0.01). EM significantly inhibited the increase in the SP levels in a dose dependent manner (P < 0.05) (see Figure 2A ).
Effects of EM
The PGE 2 levels also increased significantly in the BALF of the PC group in comparison to the NC group (P < 0.05). EM inhibited the antigen-induced PGE 2 increase in the BALF in a dose dependent manner (P < 0.01) (see Figure 2B ).
The LTBB 4 levels in the BALF increased significantly in the PC group in comparison to the NC group (P < 0.05). EM inhibited the antigen-induced LTB 4 B increase in the BALF in a dose dependent manner (P < 0.05) (see Figure 2C ).
The histamine levels also increased significantly in the BALF of PC group in comparison to the NC group (P < 0.05). EM did not significantly affect the antigen-induced histamine increase in the BALF (see Figure 2D ).
The TXB 2 levels in the BALF did not increase in the PC group in comparison to the NC group, and EM did not alter the TXB 2 levels in the BALF (data not shown).
Effect of EM on NEP activity
NEP activity decreased significantly in the PC group in comparison to the NC group (P < 0.05). EM did not prevent the decrease in the NEP activity of the tracheal tissue following the antigen challenge (see Figure 3 ).
Discussion
Macrolides, especially 14-and 15-membered macrolides [10] , have separate and distinct antibiotic and anti-inflammatory actions. Several reports have shown that 14-and 15-membered macrolides also affect the arachidonic acid cascade [21, 22] , which is associated with an increase in the cough reflex sensitivity.
However, the effects of macrolides on coughing resulting from cough reflex hypersensitivity, which is characteristic of NAEB and AC patients, have never been investigated. Therefore, in this study, we tested macrolides in an established experimental model of airway eosinophilic inflammation with cough reflex hypersensitivity [6] . The absence of the involvement of bronchoconstriction in the cough response to inhaled capsaicin in our study has been confirmed in our previous study which showed that the β2-adenoceptor agonist procaterol did not alter the number of coughs induced by inhaled capsaicin, while completely inhibiting the capsaicin-induced increase in airway resistance 24 h after an antigen challenge in this model [6] .
In this study, the doses of macrolides were found to be significantly greater than those used to treat human diseases. These doses were required to define whether or not macrolides have the potential to inhibit cough reflex hypersensitivity, because they were the maximal doses of macrolides systemically administrated among previous in vivo studies [23] [24] [25] we searched.
The present study showed for the first time that EM, a 14-membered macrolide, [29] . On the other hand, Katsumata and coworkers [30] have reported that inhaled SP induced cough in patients with upper airway infection, but not in healthy subjects. In addition, it has been shown that both the NK 1 receptor antagonist FK888 and the dual NK 1 and NK 2 peptide receptor antagonists FK224 significantly inhibited the increase in cough response to inhaled capsaicin in different types of guinea pig models of cough with allergic airway inflammation [31] [32] [33] . In our laboratory, we previously showed in the actively sensitized guinea pigs that the increase in the cough reflex sensitivity after an antigen challenge is correlated with increase in the SP levels in the BALF [18] and the decrease in the NEP activity in the tracheal tissue [19] , which are consistent with the results in the present study. Taken together, these findings suggest that the role of peripheral SP in cough reflex sensitivity may be different between species and/or employed experimental systems, especially presence of airway inflammation. We believe that at least the antigen-induced increase in the cough response to capsaicin is associated with the results from the increase of SP. Furthermore, the findings that EM reduced SP in BALF and the increase of the cough reflex sensitivity following antigen challenge are therefore considered to support our standpoints.
In addition, we also found in this study that EM dose-dependently inhibited the antigen-induced release of PGE 2 in the BALF (as is shown in a previous study [34] ) and this was correlated with the decrease in cough reflex sensitivity.
PGE 2 is a cyclooxygenase (COX)-2 metabolite of arachidonic acid released from the airway epithelium and smooth muscles during airway inflammatory reaction including NAEB [7] . There are several reports demonstrating that the number of capsaicin-induced coughs is increased in the presence of prostaglandins in the airway [35, 36] , furthermore, several other lines of evidence indicate that PGE 2 in the airway affects the cough reflex sensitivity via enhancing the sensitivity of the C-fibers to capsaicin, but does not directly stimulate the afferent fibers to induce cough [5, 37, 38] . The results that EM reduced the PGE 2 levels in BALF and cough reflex sensitivity simultaneously support the sensitizing effect of PGE 2 on C-fibers to capsaicin.
The increased vascular permeability and the subsequent interstitial airway edema evoked by the released SP and PGE 2 in the airways [39] may also stimulate and activate the afferent sensory nerves [40] . On the other hand, we also measured the histamine levels in BALF.
Histamine is a biogenic amin that is mainly released from mast cells and basophils. Moreover, it is considered to be a potent and direct activator of the afferent sensory nerves [8] and, therefore, the use of antihistamines has been recommended for the treatment of AC, thus resulting in the normalization of the cough reflex sensitivity. Our results showed that the antigen-induced increase in the histamine levels in the BALF was not affected by the administration of EM, despite a normalization of the cough reflex sensitivity. These results suggest that EM and antihistamine normalize the cough reflex sensitivity by different mechanisms. Therefore, the additional administration of EM may be effective in the treatment of atopic cough when the antihistamines alone are insufficient.
Further studies are necessary before this possibility can be established with greater certainty.
Conclusions
The present study clearly showed that 14-and 15-membered, but not Negative control, the animals received a challenge with saline and were intraperitoneally administered saline; Positive control, the animals received a challenge with OA and were intraperitoneally administered saline; Mac, macrophages;
Neu, neutrophils; Lym, lymphocytes; Eos, eosinophils; # P < 0.01 vs. negative control; † P < 0.05, ‡ P < 0.01 vs. positive control, respectively. Experiments A, B and C are 
